|Study Type:||Phase I|
|Study Start Date:||2008-03-10|
|Study Made Public:||NA|
CAVD 244 (ADVAX) is a Phase I clinical trial to evaluate the effect of two vaccinations with ADVAX (Clade C/B muligenic DNA-based vaccine) administered either via in vivo electroporation or standard intramuscular injection in 40 healthy HIV-negative volunteers.
Sign in to see full information about this study and to download study data.